Study Evaluating Efficacy & Safety of FFX Versus Combination of CPI-613

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT06155136` - RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan
Not yet recruiting	`NCT05047991` - Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma	Phase 2
Active, not recruiting	`NCT04469556` - Pancreatic Adenocarcinoma Signature Stratification for Treatment	Phase 2
Recruiting	`NCT05642962` - Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)	Phase 1/Phase 2
Withdrawn	`NCT04799431` - Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancreatic Ductal Cancer	Phase 1
Recruiting	`NCT04674956` - A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer	Phase 3
Completed	`NCT03412799` - Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer	Phase 1
Withdrawn	`NCT04852367` - PanDox: Targeted Doxorubicin in Pancreatic Tumours	Phase 1
Recruiting	`NCT04467593` - Safety Study of Whole Body Hyperthermia for Advanced Cancer	N/A
Recruiting	`NCT02959151` - A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy	Phase 1/Phase 2
Completed	`NCT01652976` - Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma	Phase 2
Completed	`NCT04721301` - Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial	Phase 1
Recruiting	`NCT04667403` - Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer	N/A
Recruiting	`NCT06168812` - A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer	Phase 2
Not yet recruiting	`NCT06076837` - The Seven Trial: Exploiting the Unfolded Protein Response	Phase 1
Active, not recruiting	`NCT03984214` - Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer	Phase 3
Recruiting	`NCT05254171` - Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer	Phase 2/Phase 3
Recruiting	`NCT04116073` - INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampullary Cancer	Phase 2
Recruiting	`NCT04338763` - RP72 Monotherapy and in Combination With Gemcitabine in Patients With Pancreatic Cancer	Phase 1
Recruiting	`NCT06030622` - Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer	Phase 1/Phase 2

NCT number	NCT03504423
Study type	Interventional
Source	Cornerstone Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	November 9, 2018
Completion date	January 2, 2022

Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms